The Nephrotic Syndrome is an immunoinflammatory disorder

Medical Hypotheses

Volumn 68, Issue 4, 2007, Pages 900-905

  Camici, Marcello ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; STEROID;

ADRENERGIC SYSTEM; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; EDEMA; EPITHELIUM CELL; GLOMERULOPATHY; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIUM; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; NEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; STRESS; SYSTEMIC CIRCULATION;

ALBUMINS; ANIMALS; CYTOKINES; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; INFLAMMATION; KIDNEY DISEASES; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEPHROTIC SYNDROME; PROTEINURIA; SIGNAL TRANSDUCTION; STEROIDS; STRESS;

EID: 33846349110     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.072     Document Type: Article

References (60)

1. Wang Y., Chen J., Chen L., Tay Y.C., Rangan G.K., and Harris D.C. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary proteins. J Am Soc Nephrol 8 (1997) 1537-1545
2. Zoya C., Donadelli R., and Colleoni S. Protein overload stimulates RANTES production by proximal tubular cells depending on NFkB activation. Kid Int 53 (1998) 934-941
3. Newman D.J., Thakkar H., and Gallagher H. Progressive renal disease: does the quality of the proteinuria matter or the only the quantity?. Clin Chim Acta 297 (2000) 43-54
4. Eddy A.A., McCulloch L., Liu E., and Adams J. A relationship between proteinuria and acute tubular interstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 138 (1991) 1111-1123
5. Diamond J.R., and Anderson S. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 137 (1990) 1323-1332
6. Remuzzi A., Gagliardini E., and Donadoni C. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kid Int 62 (2002) 885-894
7. Klahr S., Levey A.S., and beck G.J. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of diet in Renal Disease Study Group. New Eng J Med 330 (1994) 877-884
8. Maschio G., Alberti E., and Janin G. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The angiotensin-converting enzyme inhibition in Progressive Renal Insufficiency Study Group. New Eng J Med 334 (1996) 939-945
9. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., and Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New Eng J Med 345 (2001) 870-888
10. Rangan G.P., Wang Y., Tay Y.C., and Harris D.C.H. Inhibition of NFkB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kid Int 6 (1999) 116-134
11. Mudge S.J., Pizis K., Auwardt R.B., Thomas R.J., and Power D.A. Activation of nuclear factor-kB by podocytes in the autologous phase of passive Heymann nephritis. Kid Int 59 (2001) 923-931
12. Nigal Wardle E. Nuclear factor kB for the nephrologist. Nephrol Dial Transpl 16 (2001) 1764-1768
13. Guijarro C., and Egido J. Transcription factor-kB (NFkB) and renal disease. Kid Int 59 (2001) 415-424
14. Tang S., Leung J.C.K., Abe K., Chan K.W., Chan L.Y.Y., Chan T.K., et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111 (2003) 515-527
15. Nakajima H., Takenata M., Kaimori J., Hamano T., Iwatani K., Sugaya T., et al. Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 15 (2004) 276-285
16. Morigi M., Macconi D., Zoja C., Donadelli R., Buelli S., Zanchi C., et al. Protein overload-induced NFkB activation in proximal tubular cells requires H202 through a PCK-dependent pathway. J Am Soc Nephrol 13 (2002) 1179-1189
17. Iglesias J., and Levine J.S. Albuminuria and renal injury. Beware of proteins bearing gifts. Nephrol Dial Transpl 16 (2001) 215-218
18. Lohose D.L., Denu J.M., Santoro N., and Dixon J.E. Roles of aspartic acid-181 and serine -222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphate PTP1. Biochemistry 36 (1997) 4568-4575
19. Zachwieja J., Zaniew M., and Bobkowski W. Abnormal synthesis of cytokines in nephrotic syndrome. A consequence of increased oxidative stress (abstract M/80). Nephrol Dial Transpl 18 Suppl. 4 (2003) 251
20. van den Berg J.C., Aten J., Annink C., Ravesloot J.H., Weber E., and Weening J. Interleukin 4 and -13 promote basolateral secretion of H and acthepsin L by glomerular epithelial cells. Am J Physiol Renal Physiol 282 (2002) F26-F33
21. Huwiler A., Ren S., Holthofer H., Pavenstadt H., and Pfeilschi J. Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes. Biochem Biphys Res Comm 305 (2003) 136-142
22. Koukouritaki S.B., Vardaki E.A., Papakoustanti E.A., Lianos E., Stournaras C., and Emmanouel D.S. TNF α induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol Med 185 (1999) 329-339
23. Erb K.J., Ruger B., von Brevern M., Ryffel B., Schimpl A., and Rivett K. Constitutive expression on interleukin(IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185 (1997) 329-339
24. Mathieson P.W. Cytokine polymorphism and nephrotic syndrome. Clin Sci 102 (2002) 513-514
25. Tenbrock K., Schubert A., and Stapenhorst L. Type 1 IgE receptor,interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clin Sci 102 (2002) 507-512
26. van den Berg J.G., and Weening J.J. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci 107 (2004) 125-136
27. Durkan A.M., Hudson E.M., Willis N.S., and Craig J.C. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized-controlled trials. Kid Int 59 (2001) 1919-1927
28. Alsaran K., Grisaru S., Stephens D., and Arbus G. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-resistant nephrotic syndrome. Clin Nephro 56 (2001) 289-294
29. McDonald J., Murphy A.V., and Arneil G.C. Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet ii (1974) 980-982
30. Grupe W.E., Makker S.P., and Ingelfinger J.R. Chlorambucil treatment for frequently relapsing nephrotic syndrome. New Eng J Med 295 (1976) 746-749
31. Szeto C., Gillespie K.M., and Mathieson P.W. Levamisole induces interleukin -18 and shifts type1/type2 cytokine balance. Immunology 100 (2000) 217-224
32. Aviles D.H., Matti V.V., Manning J., Ochoa A.C., and Zea A.H. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kid Int 66 1 (2004) 60-67
33. Schachter A.D. The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular hetereogeneity. Pediatr Trnsplant 8 (2004) 344-348
34. Franchimont D., Kino T., Galon J., Meduri G.U., and Chrousos G. Glucocorticoids and inflammation revisited: the state of art. NIH Clinical Staff Conference. Neuroimmunomodulation 10 (2003) 247-260
35. Wolf G. "The road not taken": role of angiotensin II type 2 receptor in pathophysiology. Nephrol Dial Transpl 17 (2002) 195-198
36. Wolf G., Wensel U., Burns K.D., Harris R.C., Stahl R.A.K., and Thaissit T. Angiotensin II activates nuclear transcription factor kB through AT1 and AT2 receptors. Kid Int 61 (2002) 1986-1995
37. Ruiz-Ortega M., Lorenzo O., Ruperez M., Konig S., Wittig B., and Egido J. Angiotensin II activates nuclear transcription factor kB through AT1 and AT2 in vascular smooth muscle cells. Molecular mechanisms. Clin Res 86 (2000) 1266-1272
38. Kranzhofer R., Schmidt J., Pfeiffer C.A.M., Hagl S., Libby P., and Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscl Thromb Vasc Biol 19 (1999) 1623-1629
39. Han Y., Runge M.S., and Brasier A.R. Angiotensin II induces interleukin 6 transcription in vascular smooth muscle cells through pleiotropic activation of molecular factor-kappa B transcription factors. Circ Res 84 (1999) 695-703
40. Hahn A.W., Jonas V., Buhler F.R., and Resink K.T.J. Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347 (1994) 178-180
41. Dzau V.J. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 37 (2001) 1047-1052
42. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci 108 (2005) 205-213
43. Flenkov I.J., and Chrousos G.P. Stress hormones, proinflammatory and antinflammatory cytokines and autoimmunity. Ann New York Acad Sci 966 (2002) 290-303
44. Chrousos G.P., and Gold P.W. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267 (1992) 1244-1252
45. Chrousos G.P., and Kino T. Ikaros transcription factors:flying between stress and inflammation. J Clin Invest 115 (2005) 844-848
46. Crofford L.J. The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic disease. Endocrinol Metab Clin N Am 31 (2002) 1-13
47. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Eng J Med 332 (1995) 1351-1362
48. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2-patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10 (1999) 359-368
49. Das U.N. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 215 (2000) 145-152
50. Antonipillai I., Wang Y., and Horton R. Tumor necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 126 (1990) 273-278
51. Vallance P., Collier J., and Bhagat K. Infection, inflammation and infarction: does acute andothelial dysfunction provide a link?. Lancet 349 (1997) 1391-1392
52. Rives T.S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26 (2001) 761-788
53. Saindon C.S., Blecha F., Musch T.I., Morgan D.A., Fels R.J., and Kenny M.J. Effect of cervical vagotomy on sympathetic nerve responses to peripheral interleukin-1β. Auton Neurosci 87 (2001) 243-248
54. Dunn A.J. Cytokine activation of the HPA-axis. Ann NY Acad Sci USA 917 (2000) 608-617
55. McCann S.M., Kimura M., Karanth S., Yu W.H., Mastronardi C.A., and Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann NY Acad Sci USA 917 (2000) 4-18
56. Bamberger C.M., Schulte H.M., and Chrouses G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity. End Rev 17 (1996) 221-244
57. Luster A.D. Chemokines-Chemotactic cytokines that mediate inflammation. New Eng J Med 338 7 (1998) 436-446
58. Teran L.M., and davies D.E. The chemokines; their potential role in allergic inflammation. Clin Exp All 26 (1996) 1005-1019
59. Hans-Joachin A., Vielhamer V., and Schlonorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kid Int 68 (2003) 401-415
60. Auphan N., Didonato J.A., and Rosette C. Immunosuppression by glucocorticoids inhibition of NFkB activity through induction of IkB synthesis. Science 270 (1995) 286-290